Although ultra-long-term studies directly demonstrating the relationship between I-FABP and the growth and development of NEC infants in the years following diagnosis are currently lacking, several studies have confirmed that its high levels in the acute phase are associated with more severe disease and a higher risk of complications. The gene discussed is FABP2; the disease is necrotizing enterocolitis.